Regentis Biomaterials RGNT
NYSE RGNT
$1.51 +0.04 (+2.72%)
As of: Oct 21, 2026 · 11:11 AM EDT

Regentis Biomaterials (RGNT) Total Non-Current Liabilities (2024)

Updated

Regentis Biomaterials' Total Non-Current Liabilities was $41.43 million in Q4 2024.

Analysis

Regentis Biomaterials (RGNT) Total Non-Current Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 260.30 Bn 239.33 Bn 4.88 Bn 55.95 Bn
2 Abbott Laboratories 170.90 Bn 141.33 Bn 7.27 Bn -
3 Danaher 164.81 Bn 148.62 Bn 3.61 Bn 33.25 Bn
4 Intuitive Surgical 152.46 Bn 131.89 Bn 1.96 Bn -
5 Medtronic 119.28 Bn 84.53 Bn 6.34 Bn 38.93 Bn
6 Stryker 112.91 Bn 99.03 Bn 4.50 Bn 20.88 Bn
7 Boston Scientific 64.87 Bn 59.63 Bn 3.85 Bn 17.56 Bn
8 Becton Dickinson 53.24 Bn 50.39 Bn 2.32 Bn 23.92 Bn
9 Edwards Lifesciences 50.42 Bn 34.43 Bn 1.35 Bn 2.19 Bn
10 Regentis Biomaterials 855,783.43 855,783.43 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 41.43 Mn
API Access

Regentis Biomaterials Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNT&period=max&api_key=YOUR_API_KEY